Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308178 · ClinicalTrials.gov registry record · NA
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
A NA study, sponsored by Harold J. Burstein, MD, PhD.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00308178: Completed NA study, sponsored by Harold J. Burstein, MD, PhD.
NCT00308178 is a NA study that has completed, run by Harold J. Burstein, MD, PhD. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308178, a NA study, has completed, sponsored by Harold J. Burstein, MD, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this trial is to see if Abraxane, which is a new form of paclitaxel, is safe as a replacement form of paclitaxel in dose-dense chemotherapy. This trial will also determine if using Abraxane will allow patients to receive treatment every two weeks without requiring injects of G-CSF, a white blood cell stimulating growth factor.
Interventions
- DRUG Abraxane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00308178 record still lists
NCT00308178 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Abraxane is the first listed.
NCT00308178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308178 about?
NCT00308178 is a clinical study titled "Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer". The purpose of this trial is to see if Abraxane, which is a new form of paclitaxel, is safe as a replacement form of paclitaxel in dose-dense chemotherapy. This trial will also determine if using Abraxane will allow patients to receive treatment every two weeks without requiring injects of G-CSF, a ...
What is the current status of trial NCT00308178?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2006-03. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00308178?
The interventions under investigation include: Abraxane (DRUG).
Who is sponsoring clinical trial NCT00308178?
This trial is sponsored by Harold J. Burstein, MD, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00308178's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia